about
Development of microsponges for topical delivery of mupirocinMode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.Computer-aided design of liposomal drugs: In silico prediction and experimental validation of drug candidates for liposomal remote loading.In vitro susceptibility of Neisseria gonorrhoeae strains to mupirocin. An antibiotic reformulated to parenteral nano-liposomal antibiotic.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clinical development of mupirocin.
@en
The clinical development of mupirocin.
@nl
type
label
The clinical development of mupirocin.
@en
The clinical development of mupirocin.
@nl
prefLabel
The clinical development of mupirocin.
@en
The clinical development of mupirocin.
@nl
P1476
The clinical development of mupirocin.
@en
P2093
P304
P407
P433
P577
1990-05-01T00:00:00Z